the ticker is xlv. also had a little bit of a pullback. >> had a little pullback. opportunity. a lot of people say, man, matt, wasn't to buy stock, buy an etf but it is hitting a high. i tell them, wait for the pullback. xlv is pulling back to the sweet spot that you want to be buying and it is a lot of big drug companies. johnson & johnson, merck, pfizer, names that people didn't like for many years but now they have made a comeback. you had this emergence, the demand for health care, drugs, medical equipment, in this etf, a basket of those stocks without taking that company's specific risk to get exposure to that entire health care sector. >> matt mccall, the book is "the next great bull market," incredibly interesting tips. >>> when wl you'hether you're president obama or another candidate running for presidency, i have tips for you. x and natural minerals. give you sheer coverage instantly, then go on to even skin tone in four weeks. aveeno tinted moisturizers. ♪ well, you know i love it too ♪ ♪ you love money ♪ well, you know i love it too ♪ ♪ i work so hard a

the ticker is xlv. had a little bit of a pullback. >> it's had a little bit of a pullback, and this is the opportunity. a lot of people say, man, matt, i want to buy stock, an etf, but it's hitting a high. i tell them, wait for the pullback. xlv is pulling back to the sweet spot that you want to be buying and it's a lot of the big drug companies. johnson & johnson, merck, pfizer, names that people didn't like for many years but now they have made a comeback. again, you had this emergence of the baby boomer that has a demand for health care. whether it's drugs, medical equipment. this etf gives you a basket of those stocks without taking that company specific risk to get exposure to that entire health care sector. >> matt mccall, the book is "the next great bull market," three incredibly interesting picks. we'll watch them for you. >> whether you're president obama or many of the republican candidates running for president. i've got a message for you. it's a strong one. xyz is next. at bayer, we're re-in